SE503288C2 - Fiskvaccin omfattande en virulent, invasiv bakterie samt förfarande för framställning av detsamma - Google Patents

Fiskvaccin omfattande en virulent, invasiv bakterie samt förfarande för framställning av detsamma

Info

Publication number: SE503288C2
Authority: SE; Sweden
Prior art keywords: fish; mutant strain; strain; vaccine; spp
Prior art date: 1988-04-07

Application number

SE9003198A

Other languages

English (en)

Swedish (sv)

Other versions

SE9003198L (sv

SE9003198D0 (sv

Inventor

Hans Wolf-Watz

Anders Norquist

Aake Hagstroem

Original Assignee

Symbicom Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-04-07

Filing date

1990-10-05

Publication date

1996-05-13

1990-10-05 Application filed by Symbicom Ab filed Critical Symbicom Ab

1990-10-05 Publication of SE9003198L publication Critical patent/SE9003198L/xx

1990-10-05 Publication of SE9003198D0 publication Critical patent/SE9003198D0/xx

1996-05-13 Publication of SE503288C2 publication Critical patent/SE503288C2/sv

Links

229960005486 vaccine Drugs 0.000 title claims abstract description 67
241000894006 Bacteria Species 0.000 title claims description 57
238000004519 manufacturing process Methods 0.000 title claims description 5
241000251468 Actinopterygii Species 0.000 claims abstract description 143
241000544286 Vibrio anguillarum Species 0.000 claims abstract description 47
244000052769 pathogen Species 0.000 claims abstract description 46
230000001580 bacterial effect Effects 0.000 claims abstract description 37
230000003053 immunization Effects 0.000 claims abstract description 32
230000001717 pathogenic effect Effects 0.000 claims abstract description 32
238000007654 immersion Methods 0.000 claims abstract description 16
239000000725 suspension Substances 0.000 claims abstract description 12
230000002163 immunogen Effects 0.000 claims abstract description 10
108090000623 proteins and genes Proteins 0.000 claims description 38
230000001018 virulence Effects 0.000 claims description 36
238000000034 method Methods 0.000 claims description 32
230000000890 antigenic effect Effects 0.000 claims description 22
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 22
108091028043 Nucleic acid sequence Proteins 0.000 claims description 20
201000010099 disease Diseases 0.000 claims description 20
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 20
108020004414 DNA Proteins 0.000 claims description 19
244000052616 bacterial pathogen Species 0.000 claims description 12
JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 claims description 12
229960001225 rifampicin Drugs 0.000 claims description 12
241000607525 Aeromonas salmonicida Species 0.000 claims description 11
229960005322 streptomycin Drugs 0.000 claims description 11
241000700605 Viruses Species 0.000 claims description 8
230000002950 deficient Effects 0.000 claims description 7
241000605056 Cytophaga Species 0.000 claims description 6
239000003471 mutagenic agent Substances 0.000 claims description 6
231100000707 mutagenic chemical Toxicity 0.000 claims description 6
230000002269 spontaneous effect Effects 0.000 claims description 6
241000604777 Flavobacterium columnare Species 0.000 claims description 5
230000003505 mutagenic effect Effects 0.000 claims description 5
241000607534 Aeromonas Species 0.000 claims description 4
241000607528 Aeromonas hydrophila Species 0.000 claims description 4
241000122170 Aliivibrio salmonicida Species 0.000 claims description 4
241000607471 Edwardsiella tarda Species 0.000 claims description 4
241000606860 Pasteurella Species 0.000 claims description 4
241000190870 Sporocytophaga Species 0.000 claims description 4
241001135139 Vibrio ordalii Species 0.000 claims description 4
OEUUFNIKLCFNLN-LLVKDONJSA-N chembl432481 Chemical compound OC(=O)[C@@]1(C)CSC(C=2C(=CC(O)=CC=2)O)=N1 OEUUFNIKLCFNLN-LLVKDONJSA-N 0.000 claims description 4
239000002962 chemical mutagen Substances 0.000 claims description 4
230000007547 defect Effects 0.000 claims description 4
230000005865 ionizing radiation Effects 0.000 claims description 4
238000002955 isolation Methods 0.000 claims description 4
230000005855 radiation Effects 0.000 claims description 4
231100000111 LD50 Toxicity 0.000 claims description 3
241000186660 Lactobacillus Species 0.000 claims description 3
241000186359 Mycobacterium Species 0.000 claims description 3
241000187678 Nocardia asteroides Species 0.000 claims description 3
241000589516 Pseudomonas Species 0.000 claims description 3
108020004511 Recombinant DNA Proteins 0.000 claims description 3
230000002759 chromosomal effect Effects 0.000 claims description 3
239000001963 growth medium Substances 0.000 claims description 3
229940039696 lactobacillus Drugs 0.000 claims description 3
241000589565 Flavobacterium Species 0.000 claims description 2
241000186813 Renibacterium Species 0.000 claims description 2
241000187747 Streptomyces Species 0.000 claims 2
241000186812 Renibacterium salmoninarum Species 0.000 claims 1
241000194017 Streptococcus Species 0.000 claims 1
238000003306 harvesting Methods 0.000 claims 1
238000002649 immunization Methods 0.000 abstract description 24
241000894007 species Species 0.000 abstract description 12
238000002360 preparation method Methods 0.000 abstract description 4
208000035473 Communicable disease Diseases 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 description 25
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 24
239000013612 plasmid Substances 0.000 description 13
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
239000011780 sodium chloride Substances 0.000 description 12
238000002474 experimental method Methods 0.000 description 11
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
241000588724 Escherichia coli Species 0.000 description 8
241000277275 Oncorhynchus mykiss Species 0.000 description 8
230000036039 immunity Effects 0.000 description 8
230000028993 immune response Effects 0.000 description 7
231100000636 lethal dose Toxicity 0.000 description 7
239000000427 antigen Substances 0.000 description 6
102000036639 antigens Human genes 0.000 description 6
108091007433 antigens Proteins 0.000 description 6
238000009396 hybridization Methods 0.000 description 6
238000003780 insertion Methods 0.000 description 6
230000037431 insertion Effects 0.000 description 6
238000007912 intraperitoneal administration Methods 0.000 description 6
238000012360 testing method Methods 0.000 description 6
239000012634 fragment Substances 0.000 description 5
230000002949 hemolytic effect Effects 0.000 description 5
239000013598 vector Substances 0.000 description 5
108091034117 Oligonucleotide Proteins 0.000 description 4
241001327647 Oncorhynchus mykiss gairdneri Species 0.000 description 4
108091005804 Peptidases Proteins 0.000 description 4
239000004365 Protease Substances 0.000 description 4
239000004098 Tetracycline Substances 0.000 description 4
206010047400 Vibrio infections Diseases 0.000 description 4
230000021615 conjugation Effects 0.000 description 4
229910052742 iron Inorganic materials 0.000 description 4
239000002609 medium Substances 0.000 description 4
230000007918 pathogenicity Effects 0.000 description 4
229960002180 tetracycline Drugs 0.000 description 4
229930101283 tetracycline Natural products 0.000 description 4
235000019364 tetracycline Nutrition 0.000 description 4
150000003522 tetracyclines Chemical class 0.000 description 4
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 3
108010006464 Hemolysin Proteins Proteins 0.000 description 3
241000607598 Vibrio Species 0.000 description 3
230000002238 attenuated effect Effects 0.000 description 3
230000008901 benefit Effects 0.000 description 3
210000004027 cell Anatomy 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
210000000349 chromosome Anatomy 0.000 description 3
239000012141 concentrate Substances 0.000 description 3
239000003228 hemolysin Substances 0.000 description 3
238000011534 incubation Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
238000002347 injection Methods 0.000 description 3
244000005700 microbiome Species 0.000 description 3
230000002797 proteolythic effect Effects 0.000 description 3
239000000523 sample Substances 0.000 description 3
238000002255 vaccination Methods 0.000 description 3
230000003612 virological effect Effects 0.000 description 3
LIVXWXAMTVJGCO-UHFFFAOYSA-N 2,4-diamino-6,7-diisopropylpteridine Chemical compound NC1=NC(N)=C2N=C(C(C)C)C(C(C)C)=NC2=N1 LIVXWXAMTVJGCO-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
208000035143 Bacterial infection Diseases 0.000 description 2
101710089384 Extracellular protease Proteins 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
206010017553 Furuncle Diseases 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
208000032969 Hemorrhagic Septicemia Diseases 0.000 description 2
239000006137 Luria-Bertani broth Substances 0.000 description 2
239000007993 MOPS buffer Substances 0.000 description 2
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
241000607142 Salmonella Species 0.000 description 2
239000002253 acid Substances 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
208000022362 bacterial infectious disease Diseases 0.000 description 2
244000309464 bull Species 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
239000013611 chromosomal DNA Substances 0.000 description 2
239000013599 cloning vector Substances 0.000 description 2
230000034994 death Effects 0.000 description 2
231100000517 death Toxicity 0.000 description 2
238000001514 detection method Methods 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
IFQUWYZCAGRUJN-UHFFFAOYSA-N ethylenediaminediacetic acid Chemical compound OC(=O)CNCCNCC(O)=O IFQUWYZCAGRUJN-UHFFFAOYSA-N 0.000 description 2
208000003512 furunculosis Diseases 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
238000002744 homologous recombination Methods 0.000 description 2
230000006801 homologous recombination Effects 0.000 description 2
230000001976 improved effect Effects 0.000 description 2
230000002458 infectious effect Effects 0.000 description 2
238000001802 infusion Methods 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
208000017169 kidney disease Diseases 0.000 description 2
230000007774 longterm Effects 0.000 description 2
238000005259 measurement Methods 0.000 description 2
239000012528 membrane Substances 0.000 description 2
VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
244000000010 microbial pathogen Species 0.000 description 2
239000006151 minimal media Substances 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
229940126578 oral vaccine Drugs 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
230000003362 replicative effect Effects 0.000 description 2
239000013535 sea water Substances 0.000 description 2
239000006152 selective media Substances 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
238000002741 site-directed mutagenesis Methods 0.000 description 2
230000017105 transposition Effects 0.000 description 2
241001529453 unidentified herpesvirus Species 0.000 description 2
238000005303 weighing Methods 0.000 description 2
LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
241000252073 Anguilliformes Species 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
208000031872 Body Remains Diseases 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
241000036569 Carp sprivivirus Species 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
102100035882 Catalase Human genes 0.000 description 1
241001112695 Clostridiales Species 0.000 description 1
241000252233 Cyprinus carpio Species 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
201000000297 Erysipelas Diseases 0.000 description 1
241001646716 Escherichia coli K-12 Species 0.000 description 1
241000186394 Eubacterium Species 0.000 description 1
241000382842 Flavobacterium psychrophilum Species 0.000 description 1
241001098133 Golden shiner reovirus Species 0.000 description 1
241000700723 Ictalurid herpesvirus 1 Species 0.000 description 1
241000701372 Iridovirus Species 0.000 description 1
208000006941 Laboratory Infection Diseases 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
108010048581 Lysine decarboxylase Proteins 0.000 description 1
201000009906 Meningitis Diseases 0.000 description 1
241000187488 Mycobacterium sp. Species 0.000 description 1
229910002651 NO3 Inorganic materials 0.000 description 1
NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
206010029443 Nocardia Infections Diseases 0.000 description 1
241000277334 Oncorhynchus Species 0.000 description 1
108700005126 Ornithine decarboxylases Proteins 0.000 description 1
102000052812 Ornithine decarboxylases Human genes 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
208000014645 Pasteurella hemorrhagic septicemia Diseases 0.000 description 1
206010034107 Pasteurella infections Diseases 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
235000014676 Phragmites communis Nutrition 0.000 description 1
241000861915 Plecoglossus Species 0.000 description 1
241000589774 Pseudomonas sp. Species 0.000 description 1
241000702263 Reovirus sp. Species 0.000 description 1
241000277263 Salmo Species 0.000 description 1
241000277331 Salmonidae Species 0.000 description 1
241000277295 Salvelinus Species 0.000 description 1
241000607768 Shigella Species 0.000 description 1
241000194022 Streptococcus sp. Species 0.000 description 1
241000187180 Streptomyces sp. Species 0.000 description 1
208000037386 Typhoid Diseases 0.000 description 1
108010003533 Viral Envelope Proteins Proteins 0.000 description 1
241000607734 Yersinia <bacteria> Species 0.000 description 1
241001148129 Yersinia ruckeri Species 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
239000008272 agar Substances 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000000680 avirulence Effects 0.000 description 1
230000007921 bacterial pathogenicity Effects 0.000 description 1
238000003287 bathing Methods 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
239000006161 blood agar Substances 0.000 description 1
241001233037 catfish Species 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
230000008859 change Effects 0.000 description 1
RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
238000010367 cloning Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
230000001268 conjugating effect Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000012258 culturing Methods 0.000 description 1
230000002354 daily effect Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
239000003814 drug Substances 0.000 description 1
PZZHMLOHNYWKIK-UHFFFAOYSA-N eddha Chemical compound C=1C=CC=C(O)C=1C(C(=O)O)NCCNC(C(O)=O)C1=CC=CC=C1O PZZHMLOHNYWKIK-UHFFFAOYSA-N 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
239000002095 exotoxin Substances 0.000 description 1
231100000776 exotoxin Toxicity 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
239000007789 gas Substances 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
230000008774 maternal effect Effects 0.000 description 1
HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
229960004961 mechlorethamine Drugs 0.000 description 1
210000004379 membrane Anatomy 0.000 description 1
MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
229960004857 mitomycin Drugs 0.000 description 1
239000000203 mixture Substances 0.000 description 1
230000001483 mobilizing effect Effects 0.000 description 1
238000007479 molecular analysis Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
230000035772 mutation Effects 0.000 description 1
208000027531 mycobacterial infectious disease Diseases 0.000 description 1
TZGBBMBARSFJBG-UKTHLTGXSA-N naftazone Chemical compound C1=CC=C2C(=O)C(=N/NC(=O)N)/C=CC2=C1 TZGBBMBARSFJBG-UKTHLTGXSA-N 0.000 description 1
239000013642 negative control Substances 0.000 description 1
IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
229960001907 nitrofurazone Drugs 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
230000037361 pathway Effects 0.000 description 1
210000003200 peritoneal cavity Anatomy 0.000 description 1
238000013492 plasmid preparation Methods 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
230000008092 positive effect Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
230000001902 propagating effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
239000007320 rich medium Substances 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000012216 screening Methods 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
201000008297 typhoid fever Diseases 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/107—Vibrio
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/827—Bacterial vaccine for fish

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Wood Science & Technology (AREA)
Animal Behavior & Ethology (AREA)
Mycology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Plant Pathology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Farming Of Fish And Shellfish (AREA)
Feed For Specific Animals (AREA)

SE9003198A 1988-04-07 1990-10-05 Fiskvaccin omfattande en virulent, invasiv bakterie samt förfarande för framställning av detsamma SE503288C2 (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK189788A DK189788D0 (da)	1988-04-07	1988-04-07	Vaccine
PCT/DK1989/000075 WO1989009616A1 (fr)	1988-04-07	1989-04-06	Vaccin pour poissons comprenant une bacterie envahissante virulente

Publications (3)

Publication Number	Publication Date
SE9003198L SE9003198L (sv)	1990-10-05
SE9003198D0 SE9003198D0 (sv)	1990-10-05
SE503288C2 true SE503288C2 (sv)	1996-05-13

Family

ID=8108891

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9003198A SE503288C2 (sv)	1988-04-07	1990-10-05	Fiskvaccin omfattande en virulent, invasiv bakterie samt förfarande för framställning av detsamma

Country Status (8)

Country	Link
US (1)	US5284653A (fr)
AU (1)	AU3429389A (fr)
CA (1)	CA1335663C (fr)
DK (1)	DK189788D0 (fr)
GB (1)	GB2234436B (fr)
NO (1)	NO179360C (fr)
SE (1)	SE503288C2 (fr)
WO (1)	WO1989009616A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8912330D0 (en) *	1989-05-30	1989-07-12	Wellcome Found	Live vaccines
IE61635B1 (en) *	1990-03-13	1994-11-16	Trinity College Dublin	Improvements in vaccines
US5498414A (en) *	1992-10-05	1996-03-12	University Of Victoria	Attenuated strains of Aeromonas salmonicida useful as fish vaccines
EP0640348A1 (fr) *	1993-07-26	1995-03-01	Akzo Nobel N.V.	Mélange adjuvant à base d'huile et à base d'eau
US6010705A (en) *	1997-04-11	2000-01-04	Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College	Attenuated, invasive vaccines against fish pathogens
US6019981A (en) *	1998-03-06	2000-02-01	The United States Of America As Represented By The Secretary Of Agriculture	Modified live Edwardsiella ictaluri against enteric septicemia in channel catfish
US6153202A (en) *	1998-03-06	2000-11-28	The United States Of America As Represented By The Secretary Of Agriculture	In ovo methods for utilizing live Edwardsiella ictaluri against enteric septicemia in channel catfish
US6207179B1 (en) *	2000-05-18	2001-03-27	Phoenix Scientific, Inc.	Parasiticidal formulation for animals and a method of making this formulation
US6913757B1 (en) *	2000-07-26	2005-07-05	The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations	Live, avirulent strain of V. anguillarum that protects fish against infection by virulent V. anguillarum and method of making the same
US6881412B1 (en) *	2001-12-12	2005-04-19	The United States Of America As Represented By The Secretary Of The Agriculture	Modified live Flavobacterium columnare against columnaris disease in fish
KR101192652B1 (ko)	2003-02-06	2012-10-19	앤저 테라퓨틱스 인코퍼레이티드	비포식 세포로의 침투가 약화된 리스테리아, 리스테리아를 포함하는 백신, 및 그것의 사용방법
KR101173871B1 (ko) *	2003-02-06	2012-08-16	앤저 테라퓨틱스 인코퍼레이티드	변형된 독립생존 미생물, 백신 조성물 및 그것의 사용방법
US7695725B2 (en)	2003-02-06	2010-04-13	Aduro Biotech	Modified free-living microbes, vaccine compositions and methods of use thereof
US20050118194A1 (en) *	2003-12-01	2005-06-02	Sin Yoke M.	Oral vaccine, method for its preparation and use thereof
US6984388B1 (en) *	2004-02-06	2006-01-10	The United States Of America As Represented By The Secretary Of Agriculture	Adhesion deficient isolate of Flavobacterium columnare against columnaris disease
CN100384985C (zh) *	2004-12-14	2008-04-30	华东理工大学	鳗弧菌无标记基因缺失减毒菌株及其应用
CN1276076C (zh) *	2004-12-14	2006-09-20	华东理工大学	一种鳗弧菌野生毒株的无标记基因缺失减毒突变株及其应用
RU2284830C1 (ru) *	2005-04-18	2006-10-10	Федеральное Государственное Унитарное Предприятие Всероссийский научно-исследовательский институт рыбного хозяйства и океанографии (ФГУП ВНИРО)	Способ получения инактивированной вакцины против вибриоза рыб
RU2284831C1 (ru) *	2005-04-18	2006-10-10	Федеральное Государственное Унитарное Предприятие Всероссийский научно-исследовательский институт рыбного хозяйства и океанографии (ФГУП ВНИРО)	Инактивированная вакцина против вибриоза рыб
KR100765357B1 (ko)	2006-10-12	2007-10-10	부경대학교 산학협력단	고스트 비브리오 앵귈라룸 및 이를 함유하는 비브리오증의예방용 백신
US8518413B2 (en)	2011-04-05	2013-08-27	University Of Idaho	Probiotic bacterial strains for use to decrease mortality in fish due to bacterial disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB217008A (en) *	1923-04-27	1924-06-12	New Garter Foundry Co Ltd	Improvements in or relating to bedstead corner and like joints or connexions
FR2509177A1 (fr) *	1981-01-16	1983-01-14	Univ Washington	Vaccin pour les poissons et son procede de preparation
US4479936A (en) *	1982-09-27	1984-10-30	Microlife Technics, Inc.	Method for protecting the growth of plants employing mutant siderophore producing strains of Pseudomonas Putida
GB2170008B (en) *	1985-01-19	1988-09-01	Benham	Vibration detecting devices
IL74289A (en) *	1985-02-10	1989-02-28	Israel State	Vaccine system comprising a live-non-virulent vaccine and an adjuvant

1988
- 1988-04-07 DK DK189788A patent/DK189788D0/da not_active Application Discontinuation
1989
- 1989-04-06 US US07/601,688 patent/US5284653A/en not_active Expired - Fee Related
- 1989-04-06 AU AU34293/89A patent/AU3429389A/en not_active Abandoned
- 1989-04-06 WO PCT/DK1989/000075 patent/WO1989009616A1/fr not_active Ceased
- 1989-04-07 CA CA000596006A patent/CA1335663C/fr not_active Expired - Fee Related
1990
- 1990-10-04 GB GB9021660A patent/GB2234436B/en not_active Expired
- 1990-10-05 NO NO904342A patent/NO179360C/no not_active IP Right Cessation
- 1990-10-05 SE SE9003198A patent/SE503288C2/sv not_active IP Right Cessation

Also Published As

Publication number	Publication date
GB2234436B (en)	1992-04-22
NO179360B (no)	1996-06-17
GB2234436A (en)	1991-02-06
NO179360C (no)	1996-09-25
SE9003198L (sv)	1990-10-05
NO904342L (no)	1990-10-05
CA1335663C (fr)	1995-05-23
NO904342D0 (no)	1990-10-05
US5284653A (en)	1994-02-08
DK189788D0 (da)	1988-04-07
GB9021660D0 (en)	1990-11-21
SE9003198D0 (sv)	1990-10-05
WO1989009616A1 (fr)	1989-10-19
AU3429389A (en)	1989-11-03

Legal Events

Date

Code

Title

Description

2002-11-19

NUG

Patent has lapsed

Ref document number: 9003198-0

Format of ref document f/p: F

Publication	Publication Date	Title
SE503288C2 (sv)	1996-05-13	Fiskvaccin omfattande en virulent, invasiv bakterie samt förfarande för framställning av detsamma
US5077044A (en)	1991-12-31	Novel non-reverting shigella live vaccines
Norqvist et al.	1989	Protection of rainbow trout against vibriosis and furunculosis by the use of attenuated strains of Vibrio anguillarum
EP0315682B1 (fr)	1993-12-22	Microbes avirulents et leurs utilisations
Tacket et al.	1992	Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers
US5210035A (en)	1993-05-11	Non-reventing live vaccines
US5468485A (en)	1995-11-21	Avirulent microbes and uses therefor
EP0555366B1 (fr)	2000-06-28	Procede d'attenuation bacterienne et vaccin
US5643771A (en)	1997-07-01	Non-reverting live bacterial vaccines
CA2244807A1 (fr)	1997-08-15	Vaccin produit a partir de salmonella typhimurium
AU666108B2 (en)	1996-02-01	CDT mutants of salmonella typhi
WO1990011688A1 (fr)	1990-10-18	Microbes avirulents et leurs emplois
HU225644B1 (en)	2007-05-02	Attenuated bacteria and vaccines containing thereof
Temprano et al.	2005	Potential use of a Yersinia ruckeri O1 auxotrophic aroA mutant as a live attenuated vaccine
US6905691B1 (en)	2005-06-14	Vaccines containing attenuated bacteria
AU739191B2 (en)	2001-10-04	Vaccines containing attenuated bacteria
CN121759333A (zh)	2026-03-31	一株源自斑点叉尾鮰的杀鲑气单胞菌天然弱毒菌株及其应用